Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoying Shang

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2021
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylaseYohei Yoshihama, Kyle A LaBella, Eiru Kim, et al.
Genes & Development|January 21, 2018
Opposing roles of TGFβ and BMP signaling in prostate cancer developmentXin Lu, Eun-Jung Jin, Xi Cheng, et al.
Cell|June 22, 2024
TERT activation targets DNA methylation and multiple aging hallmarksHong Seok Shim, Jonathan Iaconelli, Xiaoying Shang, et al.
Nature|March 22, 2017
Effective combinatorial immunotherapy for castration-resistant prostate cancerXin Lu, James W Horner, Erin Paul, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Developmental Cell|April 4, 2024
Telomere dysfunction alters intestinal stem cell dynamics to promote cancerKyle A LaBella, Wen-Hao Hsu, Jiexi Li, et al.
Nature Communications|May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinomaTianhe Huang, Xi Cheng, Jad Chahoud, et al.
Nature|February 7, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancerDi Zhao, Xin Lu, Guocan Wang, et al.
Cancer Discovery|September 28, 2023
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer ProgressionWen-Hao Hsu, Kyle A LaBella, Yiyun Lin, et al.
Cancer Research|May 18, 2018
An <i>In Vivo</i> Screen Identifies PYGO2 as a Driver for Metastatic Prostate CancerXin Lu, Xiaolu Pan, Chang-Jiun Wu, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Proceedings of the National Academy of Sciences of the United States of America|September 3, 2021
AR-negative prostate cancer is vulnerable to loss of JMJD1C demethylaseYohei Yoshihama, Kyle A LaBella, Eiru Kim, et al.
Genes & Development|January 21, 2018
Opposing roles of TGFβ and BMP signaling in prostate cancer developmentXin Lu, Eun-Jung Jin, Xi Cheng, et al.
Cell|June 22, 2024
TERT activation targets DNA methylation and multiple aging hallmarksHong Seok Shim, Jonathan Iaconelli, Xiaoying Shang, et al.
Nature|March 22, 2017
Effective combinatorial immunotherapy for castration-resistant prostate cancerXin Lu, James W Horner, Erin Paul, et al.
Molecular Cancer Therapeutics|August 13, 2009
Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastomaSanjeev A Vasudevan, Xiaoying Shang, Xiaoyi Shang, et al.
Developmental Cell|April 4, 2024
Telomere dysfunction alters intestinal stem cell dynamics to promote cancerKyle A LaBella, Wen-Hao Hsu, Jiexi Li, et al.
Nature Communications|May 3, 2020
Effective combinatorial immunotherapy for penile squamous cell carcinomaTianhe Huang, Xi Cheng, Jad Chahoud, et al.
Nature|February 7, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancerDi Zhao, Xin Lu, Guocan Wang, et al.
Cancer Discovery|September 28, 2023
Oncogenic KRAS Drives Lipofibrogenesis to Promote Angiogenesis and Colon Cancer ProgressionWen-Hao Hsu, Kyle A LaBella, Yiyun Lin, et al.
Cancer Research|May 18, 2018
An <i>In Vivo</i> Screen Identifies PYGO2 as a Driver for Metastatic Prostate CancerXin Lu, Xiaolu Pan, Chang-Jiun Wu, et al.
Pageof 6